Payment Policy: Clinical Validation of Modifier 25
Defines Centene's prepayment clinical review and reimbursement policy for Evaluation and Management (E/M) services billed with Modifier 25 and describes documentation, claims review, and appeal processes affecting providers submitting such claims.
No material clinical or coverage changes in this revision.
Reimbursement Criteria for E/M with Modifier 25
Modifier 25 documentation and reimbursement criteria
Reimbursement for an E/M billed with Modifier 25 is recommended when documentation supports a significant, separately identifiable E/M service. If documentation does not indicate a separately identifiable service, the primary procedure will be reimbursed and the E/M billed with modifier 25 will be denied.
ONE of the following must be met
- The E/M is the first time the provider has seen the patient or evaluated a major condition
- A diagnosis on the claim indicates a separate medical condition was treated in addition to the procedure performed
- Patient’s condition is worsening as evidenced by diagnostic procedures being performed on the date of service
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.